Close Menu

Diagnostics Business, Policy & Funding

Breaking news on Diagnostics business, policy & funding.

The president-elect's plan would provide funding to purchase rapid tests and investments to expand lab capacity.

The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.

The test has been authorized for use with individual respiratory specimens, as well as with pooled specimens containing up to five samples.

Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials.

The company continues to face regulatory challenges in the US, but received CE marking for its DPP SARS-CoV-2 Antigen and IgM/IgG test systems.